Literature DB >> 15512808

PECAM-1, apoptosis and CD34+ precursors.

Maria R Zocchi1, A Poggi.   

Abstract

Apoptosis is a physiological process that controls tissue homeostasis, in combination with survival signals delivered by distinct receptors that bind hormones, growth factors or extracellular matrix components. The extrinsic pathway of apoptosis is due to the triggering of death receptors and the activation of the caspase cascade; the intrinsic pathway is due to withdrawal of growth factors and mainly related to mitochondrial metabolism. The choice between survival or apoptosis, which is the result of such different integrated environmental signals, is crucial for the maintainance of bone marrow reservoir of hematopoietic precursors (HPC). CD34+ HPC can receive multiple survival signals during homing and maturation, due to different interactions with adhesion molecules expressed on endothelial and bone marrow stromal cells, proteins of the extracellular matrix and chemokines or growth factors. Among them, the signal delivered via platelet endothelial cell adhesion molecule-1 (PECAM-1) seems to contribute to the resistance of this cell population to starvation, and it is related to the maintainance of mitochondrial metabolism. Indeed, this molecule, originally described as an adhesion receptor belonging to the immunoglobulin superfamily, capable of homophilic and heterophilic interactions, turned out to be a signalling molecule, containing an immunoreceptor tyrosine-based inhibitory motifs (ITIM) within its cytoplasmic domain. In particular, it has been shown that PECAM-1 binds to different kinases and phosphatases, including the phosphatidylinositide-3-kinase that phosphorylates Akt, which, in turn can upregulate transcription and function of antiapoptotic proteins, such as Bcl-2 and Bcl-x or A1, responsible for the rescue from mitochondrial apoptosis. The possible role of PECAM-1 engagement in the prevention of starvation-induced apoptosis of HPC precursors and in the maintainance of their survival is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512808     DOI: 10.1080/10428190410001724312

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus.

Authors:  Marc Douaisi; Rachel S Resop; Maho Nagasawa; Joshua Craft; Beth D Jamieson; Bianca Blom; Christel H Uittenbogaart
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

2.  Human endothelial progenitor cells isolated from COPD patients are dysfunctional.

Authors:  Xiaoran Liu; Canmao Xie
Journal:  Mol Cell Biochem       Date:  2011-12-04       Impact factor: 3.396

3.  Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.

Authors:  Julian Marcon; Anno Graser; David Horst; Jozefina Casuscelli; Annabel Spek; Christian G Stief; Maximilian F Reiser; Johannes Rübenthaler; Alexander Buchner; Michael Staehler
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

4.  Intrinsic differentiation potential of adolescent human tendon tissue: an in-vitro cell differentiation study.

Authors:  Marieke de Mos; Wendy J L M Koevoet; Holger Jahr; Monique M A Verstegen; Marinus P Heijboer; Nicole Kops; Johannes P T M van Leeuwen; Harrie Weinans; Jan A N Verhaar; Gerjo J V M van Osch
Journal:  BMC Musculoskelet Disord       Date:  2007-02-23       Impact factor: 2.362

5.  Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Xiaoran Liu; Yangli Liu; Xinyan Huang; Gengpeng Lin; Canmao Xie
Journal:  Mol Med Rep       Date:  2017-08-16       Impact factor: 2.952

Review 6.  Platelet Endothelial Cell Adhesion Molecule-1 and Oligodendrogenesis: Significance in Alcohol Use Disorders.

Authors:  Chitra D Mandyam; Emmanuel G Villalpando; Noah L Steiner; Leon W Quach; McKenzie J Fannon; Sucharita S Somkuwar
Journal:  Brain Sci       Date:  2017-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.